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Abstract 
Background 
The COVID-19 pandemic has created an unprecedented global crisis necessitating drastic 
changes to living conditions, social-life, personal freedom and economic activity. No study has 
yet examined the presence of psychiatric symptoms in the UK population in similar conditions. 
Aims 
We investigated the prevalence of COVID-19 related anxiety, generalised anxiety, depression 
and trauma symptoms in the UK population during an early phase of the pandemic, and 
estimated associations with variables likely to influence these symptoms. 
Method 
Between 23rd and 28th March 2020, a quota sample of 2025 UK adults 18 years and older, 
stratified by age, sex and household income, was recruited by online survey company Qualtrics. 
Participants completed standardised measures of depression, generalised anxiety, and trauma 
symptoms relating to the pandemic. Bivariate and multivariate associations were calculated for 
demographic and health related variables. 
Results 
Higher levels of anxiety, depression and trauma symptoms were reported compared to previous 
population studies, but not dramatically so. Anxiety or depression, and trauma symptoms were 
predicted by young age, presence of children in the home, and high estimates of personal risk. 
Anxiety and depression were also predicted by low income, loss of income, and pre-existing 
health conditions in self and other. Specific anxiety about COVID-19 was greater in older 
participants. 
Conclusions  
  UK POPULATION MENTAL HEALTH AND COVID-19  3 
 
This study showed a modest increase in the prevalence of mental health problems in the early 
stages of the pandemic and these were predicted by several specific COVID-related variables. 
Further similar surveys, particularly of those with children at home, are required as the pandemic 
progresses. 
 
KEY WORDS: COVID-19 pandemic, Anxiety, Depression, Traumatic Stress, UK general 
population survey 
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Anxiety, Depression, and Posttraumatic Stress in the UK General Population During the 2020 
COVID-19 Pandemic.   
 
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first detected in Wuhan, 
China on 31 December 2019. The disease it causes has been named COVID-19. The first UK 
coronavirus case was confirmed on 31st January 2020, and on the 11th March 2020 the World 
Health Organisation declared the global spread of COVID-19 as a pandemic. Since then there 
have been rapidly increasing cases and deaths associated with the virus globally and in the UK. 
On the evening of 23rd March 2020 the UK Prime Minister announced extensive restrictions on 
freedom of movement, the closure of non-essential businesses, and the requirement to stay at 
home except for limited purposes. The mental health consequences for the population of an 
existential threat on the scale of the current pandemic, and of the associated restrictions on 
movement and social gatherings, are not well understood. 
 
There has been research on the psychological impact of other infectious respiratory diseases 
(IRD) such as SARS, the H1N1 flu pandemic and MERS. However, with a few exceptions, 
mostly from the Far East and which have focused largely on anxiety and its impact on risk 
perception and health behaviours rather than mental health more broadly 1 2, these studies have 
predominantly considered health care workers 3 4 and patients 5. This absence of knowledge is 
troubling because there is plausible evidence from modelling that emotional and behavioural 
responses to a pandemic may affect its course 6 and because the burden of population mental ill-
health may have implications for resources during the pandemic and national recovery 
afterwards.  In 2003, the Canadian National Advisory Committee on SARS and Public Health7, 
proposed that a ‘systemic perspective’, which focused not only on medical staff and patients but 
also the general population, should be prioritised by all those engaged in IRD psychosocial 
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research. A similar approach was advocated in a recent UK expert panel convened by the 
Academy of Medical Sciences and the mental health research charity MQ. 8 
 
Here we report initial findings from the first wave of a longitudinal, multi-wave survey of the 
social and psychological impacts of COVID-19 on the UK population conducted by researchers 
in seven UK and Irish universities (the Covid-19 Psychological Research Consortium; C19PRC) 
9. Of note, in a mirror study with similar methodology, we recently reported the social and 
psychological impacts of COVID-19 on the Republic of Ireland population10. The primary aim 
of this paper is to assess the levels of anxiety, depression and traumatic stress, based on 
validated self-report measures, in a large, representative community sample during an early 
stage of the pandemic, between March 23rd and March 28th, 2020. Based on scant previous 
studies 11 2 and given the dramatic restrictions imposed because of COVID-19, we expected 
higher levels of common psychological and stress symptoms compared with previous population 
estimates. Our secondary aim was to identify groups that are psychologically vulnerable during 
the pandemic, by assessing the relationship between levels of anxiety, depression and traumatic 
stress and (1) age; (2) household income; (3) economic threat due to COVID-19; (4) health 
related risk factors (being male, self or close friend/relative having pre-existing serious health 
condition), (5) COVID-19 infection status, (6) anxiety specifically related to COVID-19, (7) 
perceived risk of COVID-19 infection, (8) living in an urban area, (9) living as a lone adult and 
(10) living with children in the home.  
 
Methods 
Recruitment and Participants  
Data collection started on 23rd March 2020, 52 days after the first confirmed COVID-19 case in 
the UK and on the same day at 8.30pm that the UK Prime Minister announced the ‘lockdown’ 
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that required all people in the UK to stay at home except for very limited purposes, and was 
completed on 28th March 2020. The fieldwork was conducted by the survey company Qualtrics. 
The UK adult population aged 18 years and older was the target population and quota sampling 
methods were used to ensure the sample was representative of this population in terms of age 
and sex, based on 2016 population estimates from Eurostat, and household income based on the 
2017 Office for National Statistics household income bands. Qualtrics provides the online 
platform to securely house data and leverages partners to connect with potential participants who 
could have been alerted to the study in one of two ways: (1) they opted to enter studies they were 
eligible for themselves by signing up to a panel platform; or (2) they received automatic 
notification through a partner router which alerted them to studies for which they were eligible 
(either via email, SMS, in-app notifications). Importantly, to avoid self-selection bias, survey 
invitations to eligible participants only provide general information and do not include specific 
details about the contents of the survey. Participants were required to be an adult (18+ years or 
older), able to read and write in English, and a resident of the UK. No other exclusion criteria 
were applied. Panel members were not obliged to take part in the study.  
 
For the purposes of quota sampling to age, sex and household income Qualtrics proceeded as 
follows during the six days of fieldwork: (1) respondents in ‘hard to reach’ quota groups (e.g. 
young adults in the highest income bands) were prioritised and targeted first; (2) next, the focus 
shifted to allow the quotas to ‘fill up’ naturally, without specific targeting; and (3) finally, a 
switch back to targeting respondents to fill incomplete quotas ensued. Participants followed a 
link to a secure website and completed all surveys online. The invite link was active for a 
participant until a quota they would have qualified for was reached but after the quota was filled, 
previously eligible respondents were prevented from taking part in this study. Participants were 
informed about the purpose of the study, that their data would be treated in confidence, that 
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geolocation would be used to determine the area in which they lived, and of the right to 
terminate the study at any time without giving a reason. All participants provided informed 
consent prior to completing the survey and were directed to contact the NHS 111 COVID-19 
helpline at the end of the survey if they experienced any distress or had additional concerns 
about COVID-19. Ethical approval for the study was granted by the ethical review board of 
Sheffield University. 
 
Qualtrics employed checks to identify and remove any participants who completed the survey in 
less than the minimum completion time to ensure responses were trustworthy (half the median 
time of the ‘soft-launch’ with 50 participants) or potential duplicate respondents. The pre-
recruitment quotas were achieved with a high level of accuracy; the quotas were obtained to 
within 1% for sex, 0.1%-0.6% for the age bands, and 0.25%-1% for the household income 
bands. The 2014 Adult Psychiatric Morbidity Survey in England estimated the rate of 
posttraumatic stress disorder to be 4.4%11; this was lower than rates for anxiety and depression. 
To detect a disorder with a prevalence of 4%, with precision of 1%, and 95% confidence level, a 
sample size of 1476 was required. However, estimating the prevalence of disorders with a low 
prevalence (< 5%) may result in a small number of ‘cases’ being identified. For instance, a 
sample size of 1476 and prevalence of 4% will identify approximately 60 cases, and if follow-up 
analyses are based only on these cases, then tests may be underpowered. To detect a correlation 
of .30, with alpha = .05, and power of .80, 84 cases is required (or an overall sample size of 
2100). As a compromise between ensuring adequate sampling to reliably estimate prevalence 
and adequate power for sub-group analysis, a target sample size of 2000 participants was set. 
Given the dual processes used by Qualtrics and partners to recruit respondents to quotas, it is not 
possible to determine the number of survey invites that were distributed to panel members, or 
indeed the number of panellists who were alerted to the survey and who did/did not complete the 
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survey (i.e. a response rate). Qualtrics did provide some metrics for the study, as follows: (1) 
159 respondents did not provide full informed consent and were screened out; 35 respondents 
who completed the survey from outside the UK or were aged under 18 years were also screened 
out; to ensure responses were trustworthy 77 participants who completed the survey in less than 
the minimum completion time were removed, as were 64 potential duplicate respondents. This 
resulted in a sample of 2025 participants who completed the survey over six days of fieldwork.  
Subsequent checks ensured that they were also representative of the population in voting history, 
number of people in household and other important demographic characteristics 9.  
 
Participants were recruited from the four countries of the UK proportional to their relative 
population size:  England (86.9%), Wales (3.1%), Scotland (7.8%), Northern Ireland (2.3%). 
The mean age of the sample was 45.44 years (Mdn = 45.00, SD = 15.90, range 18-83), and 
51.7% (n = 1047) were female, 48.0% male (n=972) and .3% (n=6) checked the 
transgender/prefer not to say/other option. Most reported that they were born in the UK (90.6%, 
n=1834) and grew up (spent most of their life up to 16 years) in the UK (92.4%, n=1872). 
Participants reported their ethnicity: White British/Irish (n=1732, 85.5%), White non-
British/Irish (n=116, 5.7%), Indian (n=41, 2.0%), Pakistani (n=27, 1.3%), Chinese (n=19, .9%), 
other Asian/ Afro-Caribbean/ African/ Arab/ Bangladeshi/ Other (n=90, 4.30%). Regarding 
highest level of educational achievement, 19.0% (n = 385) had completed O-Level/ GCSE or 
similar, 18.1% (n = 366) had completed A-Level or similar, 28.2% (n = 572) had completed an 
undergraduate degree and 15.6% (n = 316) had completed a postgraduate degree, with 19.1% 
(n=386) reporting No Qualifications, Diploma, Other qualifications or Technical qualification. 
Nearly half of the respondents were in full-time employment (48.8%, n = 988), 15.0% (n = 303) 
were in part-time employment, 16.5% (n = 334) were retired, 4.7% (n=95) were students, and 
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5.1% (n = 103) were currently unemployed and seeking work, 3.4% (n=69) were not working 
due to disability, and 6.6% (n=133) were unemployed and not seeking work.  
Measures 
Demographic: Self-reported gender and age were recorded, and age was also categorised into a 
6-level variable for the regression analysis. 
Living Area: Participants were asked “Do you consider yourself to live in:” and were required to 
choose one of the options provided: ‘City’, ‘Suburb’, ‘Town’, or ‘Rural’. 
Lone adult: Participants were asked “How many adults (18 years or above) live in your 
household (including yourself)?” and were provided with options ranging from ‘1’ to ’10 or 
more’. The data were recoded into a binary variable to represent living alone.  
Children: participants were asked “How many children (below the age of 18) live in your 
household?” and were provided with options ranging from ‘1’ to ’10 or more’. The scores were 
categorised into 4 groups (0, 1, 2, 3 or more children). 
Income: Participants were asked “Please choose from the following options to indicate your 
approximate gross (before tax is taken away) household income in 2019 (last year). Include 
income from partners and other family members living with you and all kinds of earnings 
including salaries and benefits” to choose one of 5 categories: “£0 - £300 per week (equals about 
£0 - £1290 per month or £0 - 15,490 per year)”, “£301 - £490 per week (equals about £1,291 - 
£2,110 per month or £15,491 - £25,340 per year)”, “£491 - £740 per week (equals about £2,111 
- £3,230 per month or £25,341 - £38,740 per year)”, “£741 - £1,111 per week (equals about 
£3,231 - £4,830 per month or £38,741 - £57,930 per year)”, and “£1,112 or more per week 
(equals about £4,831 or more per month or £57,931 or more per year)”. 
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Loss of income: Participants were asked “Some people have lost income because of the 
coronavirus COVID-19 pandemic, for example because they have not been able to work as 
much or because business contracts have been cancelled or delayed. Please indicate whether 
your household has been affected in this way” and the response options were “My household 
has lost income because of the coronavirus COVID-19 pandemic”, “My household has not lost 
income because of the coronavirus COVID-19 pandemic”, “I do not know whether my 
household has lost income because of the coronavirus COVID-19 pandemic”. The first option 
was considered as ‘Yes’ (1) and the other options were collapsed to represent ‘No’. 
Heath problems: Participants were asked “Do you have diabetes, lung disease, or heart disease?” 
and the response options were ‘Yes’ (1) and ‘No’ (0). They were also asked “Do any of your 
immediate family have diabetes, lung disease, or heart disease?” and the response options were 
‘Yes’ (1) and ‘No’ (0).  
Covid-19 status, self and other: Participants were asked “Have you been infected by the 
coronavirus COVID-19?” and six responses were provided. These were collapsed into a binary 
variable representing ‘Perceived infection status’. Positive perceived infection status was based 
on the selection of either, ‘I have the symptoms of the COVID-19 virus and think I may have 
been infected’ or ‘I have been infected by the COVID-19 virus and this has been confirmed by a 
test’. Negative perceived infection status was based on the selection of either, ‘No. I have been 
tested for COVID-19 and the test was negative’, ‘No, I do not have any symptoms of COVID-
19’, ‘I have a few symptoms of cold or flu but I do not think I am infected with the COVID-19 
virus’ or ‘I may have previously been infected by COVID-19 but this was not confirmed by a 
test and I have since recovered’. Positive status (self) was coded ‘1’ and negative status coded as 
‘0’.  
Participants were also asked “Has someone close to you (a family member or friend) been 
infected by the coronavirus COVID-19?” and four responses were provided. These were 
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collapsed into a binary variable representing ‘Perceived infection status – someone close’. 
Positive perceived infection status was based on the selection of either, ‘Someone close to me 
has symptoms, and I suspect that person has been infected’ or ‘Someone who is close to me has 
had a COVID-19 virus infection confirmed by a doctor’. Negative perceived infection status 
was based on the selection of either, ‘No’ or ‘Someone close to me has symptoms, but I am not 
sure if that person is infected’. Positive status (other) was coded ‘1’ and negative status coded 
as ‘0’. 
Perceived risk of COVID-19 infection: Participants were asked “What do you think is your 
personal percentage risk of being infected with the COVID-19 virus over the following time 
periods?”, and three sliders were presented, one for each time period; (1) In the next month, (2) 
In the next three months, (3) In the next six months? The slider had ‘0’ and ‘100’ at the left and 
right hand extremes respectively, showed 10 point increments, and the labels ‘No Risk’, 
‘Moderate Risk’ and ‘Great Risk’ were shown on the left, middle and right-hand part of the scale 
respectively. These produced continuous scores, for each time period, ranging from 0 to 100 
with higher scores reflecting higher levels of perceived risk of being infected by COVID-19. The 
scores were recoded into ‘Low’ (0 - 33), ‘Moderate’ (34 - 67), and ‘High’ (68 - 100). 
Depression: Nine symptoms of depression were measured using the Patient Health 
Questionnaire-9 (PHQ-9).13 Participants indicate how often they have been bothered by each 
symptom over the last two weeks using a four-point Likert scale ranging from 0 (Not at all) to 3 
(Nearly every day). Possible scores range from 0 to 27, with higher scores indicative of higher 
levels of depression. To identify participants likely to meet the criteria for depressive disorder a 
cut-off score of 10 was used. This cut-off produces adequate sensitivity (.85) and specificity 
(.89), corresponds to ‘moderate’ levels of depression 14, and is used to identify a level of 
depression that may require psychological intervention 15.  The psychometric properties of the 
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PHQ-9 scores have been widely supported, and the reliability of the scale among the current 
sample was excellent (α = .92).  
Generalized Anxiety: Symptoms of generalized anxiety were measured using the Generalized 
Anxiety Disorder 7-item Scale (GAD-7) 16. Participants indicate how often they have been 
bothered by each symptom over the last two weeks on a four-point Likert scale (0 = Not at all, to 
3 = Nearly every day). Possible scores range from 0 to 21, with higher scores indicative of 
higher levels of anxiety. A cut-off score of 10 was used, and this has been shown to result in 
sensitivity of 89% and a specificity of 82%16. The GAD-7 has been shown to produce reliable 
and valid scores in community studies 16 and the reliability in the current sample was high (α = 
.94).  
Traumatic Stress: The International Trauma Questionnaire 18 is a self-report measure of ICD-11 
PTSD based on a total of six symptoms across the three symptom clusters of Re-experiencing, 
Avoidance, and Sense of Threat; each symptom cluster is comprised of 2 symptoms. Participants 
were asked to complete the ITQ “…in relation to your experience of the COVID-19 pandemic. 
Please read each item carefully, then select one of the answers to indicate how much you have 
been bothered by that problem in the past month”. The PTSD symptoms are accompanied by 
three items measuring functional impairment caused by these symptoms. All items are answered 
on a five-point Likert scale, ranging from 0 (Not at all) to 4 (Extremely) with possible scores 
ranging from 0 to 24. A score of ≥ 2 (Moderately) is considered ‘endorsement’ of that symptom. 
A PTSD diagnosis requires traumatic exposure, and at least one symptom to be endorsed from 
each PTSD symptom cluster (Re-experiencing, Avoidance, and Sense of Threat), and 
endorsement of at least one indicator of functional impairment. The psychometric properties of 
the ITQ scores have been demonstrated in multiple general population 19, 20 and clinical and high 
risk samples 21,22. The reliability of the PTSD items was high (α = .93). 
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Covid-19 related anxiety: The survey included a question “How anxious are you about the 
coronavirus COVID-19 pandemic?” and the participants were provided with a ‘slider’ 
(electronic visual analogue scale) to indicate their degree of anxiety with ‘0’ and ‘100’ at the left 
and right hand extremes respectively, and 10 point increments. This produced continuous scores 
ranging from 0 to 100 with higher scores reflecting higher levels of COVID-19 related anxiety. 
The scores were recoded into quintiles, and the upper quintile was considered to be indicative of 
‘COVID-19 anxiety’. 
Similar recruitment strategies and measures have been used by international collaborators in 
other countries such as Ireland10, Italy, Spain, Saudi Arabia and United Arab Emirates. 
Analysis Plan 
The analyses were conducted in 3 linked phases. First, the prevalence of generalised anxiety, 
depression and traumatic stress was estimated using the established cut-off scores. Second, the 
bivariate associations between the predictor variables and the mental health variables were 
calculated using logistic regression and the assocations were reported as odds ratios (ORs)  with 
95% confidence intervals (CI). Third, all predictor variables were entered simulataneously into 
multivariate binary logistic regression models to estimate the unique effect of each predictor 
variable, and the associations were reported as ORs.    
 
Results 
Based on the cut-off scores for the GAD-7 and the PHQ-9 the prevalence of depression was 
22.1% (95% CI 20.3 - 23.9%) and for anxiety the prevalence was 21.6% (95% CI 19.8 - 23.4%). 
There was no significant difference between prevalence of depression for males and females (χ2 
(1) = 2.34, p = .12), but significantly more females (25.1%) screened positive for anxiety than 
males (17.9%: χ2 (1) = 15.48, p < .001).  A variable was computed to represent participants who 
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screened positive for the most common mental health disorders (Anxiety/Depression), either 
anxiety or depression, the prevalence for this was 27.7% (95% CI 25.8 - 29.7%), and the 
prevalence was higher for females (31.7%) than males (23.4%: (χ2 (1) = 17.57, p < .001). Using 
the diagnostic algorithm for the ITQ the prevalence of traumatic stress was 16.79% (95% CI 
15.2- 18.4%). There was a significant sex difference with a higher prevalence of traumatic stress 
for males (18.9%) compared to females (14.9%: χ2 (1) = 5.85, p < .01). The COVID-19 anxiety 
prevalence was 21.3% (95% CI 19.5 - 23.1%) and there was a significant sex difference with a 
higher prevalence of COVID-19 anxiety for females (24.6%) compared to males (17.7%: χ2 (1) 
= 5.85, p < .01). 
Three binary logistic regression models were used to predict caseness on COVID-19 related 
anxiety, Anxiety/Depression, and traumatic stress. The predictor variables were age, gender, 
living location, lone adult, number of children, income, loss of income, pre-existing health 
condition (self and other), COVID-19 infection status (self and other), and personal risk of 
infection over the following month.  
INSERT TABLE 1 ABOUT HERE 
Table 1 shows the findings for COVID-19 related anxiety, stratified by the predictor variables, 
with bi-variate associations (unadjusted) presented as odds ratios (OR), and ORs from the 
multivariate (adjusted) model with all predictors entered. The multivariate model was significant 
(χ2 (24) = 139.97, p < .001). When the unadjusted odds ratios were calculated, only female 
gender, the presence of children in the household and estimates of personal risks of infection 
were predictive of COVID-related anxiety. However, when the adjusted effects were calculated, 
the effect for the presence of children became stronger; there was an effect for a history of 
infection, which should be interpreted with caution in the light of the small numbers involved; 
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and there was a very strong effect for age, with older participants reporting more anxiety about 
the virus. 
INSERT TABLE 2 AND 3 ABOUT HERE 
The multivariate regression models for both Anxiety/Depression (χ2 (24) = 292.03, p < .001), 
and traumatic stress (χ2 (24) = 328.58, p < .001) were statistically significant, and the unadjusted 
and adjusted odds ratios are shown in Tables 2 and 3. For Anxiety/Depression there is a strong 
effect for age, but this runs contrary to the effect observed for COVID-related anxiety, with very 
high levels of psychological symptoms in the youngest participants and low levels in those 
above 65 years of age. A bivariate effect for urban location does not survive in the multivariate 
model, and the effect for having children in the house is much muted in the multivariate model. 
Participants who had lost income in the pandemic and those in the lower income categories 
showed markedly higher risk for anxiety/depression. Higher levels of Anxiety/Depression were 
also reported by those who had pre-existing health conditions, knew someone who had a pre-
existing health condition, had become infected themselves and/or gave a high estimate of their 
personal risk of infection. 
Finally, in the case of traumatic stress, there was again a higher prevalence in younger 
participants but the gender effect was reversed compared with Anxiety/Depression, with more 
symptoms being reported by males. The influence of the presence of children was marked for 
both the bivariate associations and the multivariate model, but there was little effect for income 
or loss of income when the other variables were controlled for. The lack of an association for 
being infected by COVID-19 in the multivariate model should be interpreted with caution 
given the small numbers involved and the wide confidence intervals. Trauma symptoms were 
also associated with the perception of a high risk of infection. 
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Discussion 
This study study is one of the first to measure psychological disorders in a representative sample 
of the UK population during a pandemic. The study has the additional virtues of recruiting 
participants early in the crisis and using standardised measures, allowing follow-up at later 
stages. We found higher levels of anxiety, depression and traumatic stress than previously 
reported from general population based studies. Although previous studies have investigated the 
psychological impact of past pandemics, particularly the SARS and H1N1 pandemics in the Far 
East, they have mostly considered the effects on pandemic survivors and health professionals 
and the only population-based studies have not used standardised instruments. For example, a 
study in Taiwan following the 2003 SARS pandemic used a five-item symptom rating scale, 
finding that poorer mental health was related to personal experience of SARS or knowing people 
who had been affected 11. In a Chinese study that employed a short questionnaire during the 
same pandemic, respondents reported increased fear, anxiety and panic 2. However, a 
longitudinal study of citizens of Hong King during the 2009 H1N1 pandemic found low levels of 
anxiety throughout, but anxiety levels were associated with compliance with social distancing 
advice 1.  
 
Our primary aim was to assess the levels of anxiety, depression, and traumatic stress in the 
population during the early stages of the COVID-19 pandemic. The prevalence of anxiety 
(21.63%) and depression (22.12%) found in this study appear to be higher than those previously 
reported, but not markedly so. The English 2014 Adult Psychiatric Morbidity Survey (APMS) 22 
reported that 15.7% of the sample experienced symptoms of common mental health disorders, 
based on a cut-off score of 12 on the Clinical Interview Schedule- Revised, with a higher 
prevalence for women (19.1%) than men (12.2%). The prevalence of anxiety or depression from 
the Understanding Society study in 2014 was 19.7% (22.5% females, 16.8% males) 24 based on 
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the General Health Questionnaire (GHQ). The closest comparable study is probably the NIHR 
ARC North West Coast Household Health Survey, which administered the PHQ9 and GAD7 
(although administered face-to-face) to 4,000 people in the North West of England, mainly 
living in deprived areas; in this study, 17% were depressed and 13% were anxious 25. A recently 
published study used data from the ‘Understanding Society COVID-19 web survey’ and 
reported the population prevalence of clinically significant levels of mental distress to be 
27·3%226. The study used the GHQ to identify clinically significant distress, and data collection 
was approximately one month after our data collection period, but despite these differences the 
GHQ prevalence is similar to that based on meeting the criteria for either anxiety or depression 
in this study, which was 27.7%. This may be indicative of a stable psychological response 
during the first month of Lockdown, although longitudinal studies will be required to determine 
the longitudinal change during Lockdown.   
 
The prevalence of PTSD in this current study  was 16.79% and is similar to the combined 
prevalence of PTSD and Complex PTSD in a UK trauma exposed sample (PTSD prevalence of 
5.3% and 12.9% for Complex PTSD 27), and much higher than that reported from the APMS 
(4.4% and no gender differences were found11). However, these comparisons should be treated 
with caution as the status of COVID-19 as a traumatic stressor is not clear. Unexpectedly, the 
prevalence for males was higher than females; most epidemiological studies report higher 
prevalence of PTSD for females28. The reasons for this are not immediately clear, but the health 
and economic threat that COVID-19 poses, may be undermining traditional male gender roles, 
or the higher prevalence of mortality for males during the British COVID-19 pandemic may be 
playing a role.  
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The unadjusted estimates for the model predicting Anxiety/Depression revealed that younger 
age, being female, living in a city, pre-existing health conditions, COVID-19 status, and 
perceived risk of COVID-19 infection all significantly increased the likelihood of screening 
positive for anxiety or depression. 
Contrary to expectations, the oldest age group and being male were associated with a lower 
likelihood of anxiety or depression, despite these factors being associated with a higher COVID-
19 related mortality29. In the 2014 Adult Psychiatric Morbidity Survey, much lower prevalence 
of common psychological disorders were observed in those over 65 compared with those of 
working age, although the effect was nonlinear and the high prevalence observed for under 35s 
in this study were not evident there. Strikingly, the opposite relationship with age was observed 
for anxiety specifically about the COVID-19 pandemic, which was related to mortality risk in a 
logical way. The adjusted estimates were generally attenuated, but the same pattern of 
associations was found. The unadjusted estimates for the model predicting traumatic stress 
differed in that being male was a significant risk factor, and there was a large effect for living in 
an urban area. 
 
This study has both strengths and limitations. On the strengths side, the sample was highly 
representative of the UK population, was recruited early in the progress of the pandemic, and 
used standardised measures, allowing comparisons with findings from later stages of the Covid-
19 crisis. However, despite the sampling frame and large sample size, and although the 
participants in this study were representative of the UK population on demographic, economic 
and social factors, as well as voting history, it was not a true random probability sample (which 
would have been very difficult to obtain under the current circumstances) and it is possible that 
individuals’ decisions about whether to participate were affected by psychological factors, 
creating the possibility of sampling bias. Second, all mental health assessments were based on 
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self-report and not clinician administered interviews, and this may have resulted in over-
estimation of prevalence. Third, the validity of the assessment of traumatic stress may be 
questioned as it is not clear if the COVID-19 pandemic meets the ICD-11 criteria (“…an 
extremely threatening or horrific event or series of events”) or DSM-5 criteria (direct exposure, 
witnessing the trauma, learning that a relative or close friend was exposed to a trauma, indirect 
exposure to aversive details of the trauma, usually in the course of professional duties) for a 
traumatic event for the entire population. This question is already being debated 30 with 
arguments being made that the global nature of the threat, its wide ranging effects (i.e. health, 
economic and social), and the widespread reports of behaviours and cognitions analogous to 
PTSD symptoms (heightened perceptions of threat, voluntary (and enforced) avoidance, and re-
experiencing being facilitated by mainstream and social media), means that the pandemic should 
be considered a  traumatic stressor. Finally, the mechanisms by which the threat of the pandemic 
and/or the quarantine influence mental health could not be established. Previous research has 
identified disruptions in the circadian rhythm31, disruptions in social contact32, and quarantine 
related stressors as important contributing factors33. 
 
Conclusions 
Modelling studies have suggested that the impact of pandemics on psychological disorders in the 
general population may affect the progress of a pandemic and, therefore, indirectly affect 
mortality 6. Furthermore, the development of psychological disorders in the population may 
create a burden that impedes national social and economic recovery once the pandemic ends.  
The fact that the prevalence of psychological problems observed in the present study was not 
dramatically higher than those reported in previous studies suggests that the population, at an 
early stage of the pandemic, has successfully adapted to the unprecedented changes that have 
been forced on their lifestyles. However, we have identified certain key groups who may be 
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more vulnerable to the social and economic challenges of the pandemic, particularly those 
whose income has been affected, who have children living in the home and who have pre-
existing health conditions that make them vulnerable to the more devastating effects of the 
COVID-19 virus. Further research is needed to track whether these groups show higher levels of 
psychological problems at later stages in the pandemic and whether specific interventions and 
policies should be developed to address their needs.    
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Table 1:  Bivariate and Multivariate Binary Logistic Regression Results Predicting COVID-
Related Anxiety 
 
  COVID-19 
Anxiety 
Unadjusted OR Adjusted OR 
 N N (%)   
Age     
18-24 246 42 (17.1%) - - 
25-34 380 66 (17.4%) 1.02 (.667 - 1.56) .93 (.59 - 1.46) 
35-44 353 75 (21.2%) 1.31 (.86 - 1.99) 1.40 (.88 - 2.21) 
45-54 410 96 (23.4%) 1.48 (.99 - 2.22) 1.99 (1.28 - 3.07)** 
55-64 349 84 (24.1%) 1.54 (1.02 - 2.33)* 2.58 (1.63 - 4.08)*** 
65+ 287 68 (23.7%) 1.51 (.98 - 2.32) 2.42 (1.50 - 3.91)*** 
Gender     
Female 1047 258 (24.6%) - - 
Male 972 172 (17.7%) .65 (.53 - .82)*** .586 (.463 - .743)*** 
Living location     
Rural 335 74 (22.1%) - - 
Town 620 130 (21.0%) .94 (.68 - 1.29) .92 (.65 - 1.29) 
Suburb 572 106 (18.5%) .80 (.57 - 1.12) .77 (.54 - 1.09) 
City 498 121 (24.3%) 1.13 (.81 - 1.57) 1.20 (.84 - 1.71) 
Lone Adult     
No 1571 337 (21.5%) - - 
Yes 454 94 (20.7%) .96 (.740 - 1.24) .971 (.716 - 1.317) 
Children     
0 1429 283 (19.7%) - - 
1 292 56 (19.1%) .96 (.70 - 1.32) 1.09 (.77 - 1.55) 
2 237 73 (30.7%) 1.80 (1.33 - 2.44)*** 2.11 (1.49 - 2.98)*** 
3 + 61 19 (31.1%) 1.84 (1.05 - 3.21)* 2.35 (1.29 - 4.28)** 
Income     
£57,930 + 410 77 (18.8%) - - 
- £57,930 pa 410 86 (21.0%) 1.15 (.81 - 1.62) 1.15 (.80 - 1.65) 
- £38,740 pa 385 88 (22.9%) 1.28 (.91 - 1.81) 1.40 (.97 - 2.03) 
- £25,340 pa 410 86 (21.0%) 1.15 (.82 - 1.62) 1.37 (.94 - 2.02) 
£0 - 15,490 pa 410 94 (22.9%) 1.29 (.92 - 1.80) 1.30 (.881 - 1.92) 
Lost income     
Not lost  1377 282 (20.5%) - - 
Lost  648 149 (23.0%) 1.16 (.93 - 1.45) 1.18 (.93 - 1.51) 
Pre-existing health condition, self   
No 1714 348 (20.3%) - - 
Yes 311 83 (26.7%) 1.43 (1.08 - 1.89)* 1.24 (.91 - 1.69) 
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* p <.05, ** p <.01, ***p <.001. 
 
  
Pre-existing health condition, someone 
close 
  
No 1510 305 (20.2%) - - 
Yes 515 126 (24.5%) 1.28 (1.01 - 1.62)* 1.07 (.82 - 1.39) 
COVID-19 Self     
No 1977 425 (21.5%) -  
Yes 48 6 (12.5%) .52 (.22 - 1.23) .39 (.16 - .99)* 
Covid-19 Someone close   
No 1913 407 (21.3%) - - 
Yes 112 24 (21.4%) 1.01 (.63 - 1.61) .89 (.54 - 1.45) 
Personal Risk 1month   
Low 633 81 (12.8%) -  
Moderate 867 182 (21.0%) 1.81 (1.36 - 2.41)*** 1.75 (1.31 - 2.34)*** 
High 525 168 (32.0%) 3.21 (2.38 - 4.31)*** 3.14 (2.31 - 4.28)*** 
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Table 2:  Bivariate and Multivariate Binary Logistic Regression Results Predicting 
Anxiety/Depression 
 
  Anxiety/ 
Depression 
Unadjusted OR Adjusted OR 
 N N (%)   
Age     
18-24 246 121 (49.2%) - - 
25-34 380 152 (40.0%) .69 (.50 -.95)* .67 (.47 -.95)* 
35-44 353 97 (27.5%) .39 (.278 - .551)*** .408 (.28 - .60)*** 
45-54 410 96 (23.4%) .32 (.22 - .44) *** .36 (.25 - .52)*** 
55-64 349 68 (19.5%) .25 (.17 - .36) *** .31 (.21 - .47)*** 
65+ 287 28 (9.8%) .11 (.07 - .18) *** .141 (.09 - .23)*** 
Gender     
Female 1047 227 (23.4%) - - 
Male 972 332 (31.70%) .65 (.54-.80)*** .89 (.71 -1.12) 
Living location     
Rural 335 77 (23.0%) - - 
Town 620 167 (26.9%) 1.23 (.91 - 1.68) 1.02 (.73 -1.43) 
Suburb 572 138 (24.1%) 1.06 (.77 - 1.46) .98 (.70 - 1.39)  
City 498 180 (36.1%) 1.90 (1.39 -2.59)*** 1.21 (.86 -1.7) 
Lone Adult     
No 1571 424 (27.0%) - - 
Yes 454 138 (30.4%) 1.18 (.94 - 1.48) 1.32 (.99 - 1.75) 
Children     
0 1429 355 (24.8%) - - 
1 292 95 (32.4%) 1.46 (1.11 - 1.91)** 1.19 (.88 – 1.61) 
2 237 90 (37.8%) 1.84 (1.38 - 2.46)*** 1.41 (1.01 – 1.96)* 
3 + 61 22 (36.1%) 1.71  (1.00 - 2.93)* 1.41 (.79 – 2.53) 
Income     
£57,930 + 410 70 (17.1%) - - 
- £57,930 pa 410 91 (22.2%) 1.39 (.98 - 1.96) 1.28 (.89 - 1.85) 
- £38,740 pa 385 117 (30.4%) 2.12 (1.51 - 2.97)*** 1.69 (1.17 – 2.44)** 
- £25,340 pa 410 135 (32.9%) 2.38 (1.71 - 3.31)*** 1.67 (1.15 – 2.42)** 
£0 - 15,490 pa 410 149 (36.3%) 2.77 (2.00 - 3.84)*** 2.44 (1.67 - 3.56)*** 
Lost income     
Not lost  1377 323 (23.5%) - - 
Lost  648 239 (36.9%) 1.91 (1.56 - 2.33)*** 1.25 (1.25 – 1.95)*** 
Pre-existing health condition, self   
No 1714 452 (26.4%) - - 
Yes 311 110 (35.4%) 1.53 (1.18 - 1.97)** 1.45 (1.07 -1.96)* 
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* p <.05, ** p <.01, ***p <.001. 
 
  
Pre-existing health condition, someone 
close 
  
No 1510 386 (25.6%) - - 
Yes 515 176 (34.2%) 1.51 (1.22 - 1.88)*** 1.33 (1.03 - 1.74)* 
COVID-19 Self     
No 1977 535 (27.1%) -  
Yes 48 27 (56.3%) 3.46 (1.94 - 6.18)*** 2.17 (1.14 - 4.11)** 
Covid-19 Someone close   
No 1913 515 (26.9%) - - 
Yes 112 47 (42.0%) 1.96 (1.33 - 2.89)** 1.50 (.97 - 2.32) 
Personal Risk 1month   
Low 633 139 (22.0%) - - 
Moderate 867 208 (24.0%) 1.12 (.88 - 1.43) 1.13 (.87  - 1.47) 
High 525 215 (41.0%) 2.46 (1.91 - 3.18)*** 2.20 (1.66 - 2.91)*** 
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Table 3. Bivariate and Multivariate Binary Logistic Regression Results Predicting Traumatic 
Stress 
 
  Traumatic 
Stress 
Unadjusted OR Adjusted OR 
 N N (%)   
Age     
18-24 246 59 (24.0%) - - 
25-34 380 109 (28.7%) 1.27 (.88 - 1.84) .99 (.65 - 1.49) 
35-44 353 88 (24.9%) 1.05 (.72 - 1.54) .74 (.48 - 1.15) 
45-54 410 53 (12.9%) .47 (.31 - .71)*** .39 (.25 - .62)*** 
55-64 349 24 (6.9%) .23 (.14 - .39)*** .31  (.18 - .54)*** 
65+ 287 7 (2.4%) .08 (.03-.18)*** .09 (.04 - .22)*** 
Gender     
Female 1047 156 (14.9%) - - 
Male 972 184 (18.9%) 1.33 (1.06 - 1.68)* 1.85 (1.41 - 2.44) *** 
Living location     
Rural 335 36 (10.7%) - - 
Town 620 76 (12.3%) 1.16 (.76 - 1.77) .94 (.60 - 1.50) 
Suburb 572 88 (15.4%) 1.51 (.99 - 2.28) 1.24 (.79 - 1.94) 
City 498 140 (28.1%) 3.25 (2.18 - 4.83)*** 1.91 (1.23 - 2.94)** 
Lone Adult     
No 1571 268 (17.1%) - - 
Yes 454 72 (15.9%) .92 (.69 – 1.22) 1.412 (.99 – 2.00) 
Children     
0 1429 163 (11.4%) - - 
1 292 75 (25.6%) 2.68 (1.96 - 3.65)*** 1.83 (1.30 – 2.58)** 
2 237 83 (34.9%) 4.17 (3.05 - 5.70)*** 2.56 (1.78 – 3.68)*** 
3 + 61 19 (31.1%) 3.52 (2.00 - 6.21)*** 2.39 (1.29 – 4.44)** 
Income     
£57,930 + 410 49 (12.0%) - - 
- £57,930 pa 410 59 (14.4%) 1.24 - (.82 - 1.86) 1.27 (.82 – 1.98) 
- £38,740 pa 385 81 (21.0%) 1.96 (1.33 - 2.88)** 1.55 (.99- 2.40) 
- £25,340 pa 410 98 (23.9%) 2.31 (1.59 - 3.36)*** 1.85 (1.19  - 2.87)** 
£0 - 15,490 pa  410 53 (12.9%) 1.09 (.72 - 1.65) 1.28 (.78 – 2.07) 
Lost income     
Not lost  1377 196 (14.2%) - - 
Lost 648 144 (22.2%) 1.722 (1.36  - 2.18)*** 1.27 (.97 – 1.66) 
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* p <.05, ** p <.01, ***p <.001. 
 
  
Pre-existing health condition,  
self 
No 1714 279 (16.3%) - - 
Yes 311 61 (19.6%) 1.25 (.92 - 1.71) 1.21 (.829 - 1.77) 
Pre-existing health condition,  
someone close 
  
No 1510 247 (16.4%) - - 
Yes 515 93 (18.1%) 1.13 (.87 - 1.46) 1.13 (.82 - 1.56) 
Covid-19 Self     
No 1977 324 (16.4%) - - 
Yes 48 16 (33.3%) 2.55 (1.38 - 4.70)** 1.03 (.50 -  2.12) 
Covid-19 Someone close   
No 1913 305 (15.9%) - - 
Yes 112 35 (31.3%) 2.39 (1.57 - 3.64)*** 1.70 (1.04 -  2.77)* 
Personal Risk 1month   
Low 633 54 (8.5%) - - 
Moderate 867 132 (15.2%) 1.92 (1.37 - 2.69)*** 1.88 (1.32 - 2.68)** 
High 525 154 (29.3%) 4.45 (3.18 - 6.23)*** 3.55 (2.47 - 5.09)*** 
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